|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Breastfeeding rates and hospital breastfeeding practices in Canada: A national survey of women显示文摘 | Beverley C Cheryl L Maureen H | 2009 | BIRTH2009，36，2： | 1 |
| 2 | The Walk the Talk Team: the Secrets of Highly Active Older Adults显示文摘 | THEA F CATHERINE T MAUREEN C | 2013 | Journal of Aging Studies2013，27，3： | 1 |
| 3 | First-year development of plant communities originating from forest topsoils placed on southern Appalachian mine soils显示文摘 | Robert E Farmer J Maureen C | 1982 | Journal of Applied Ecology1982，19，1： | 1 |
| 4 | Color and brightness appearance issues in tiled displays 显示文摘 | Stone Maureen C | 2001 | Computer Graphics and Applications2001，21，5： | 1 |
| 5 | Aerosol optical properties and their radiative effects in norhern China 显示文摘 | LI Z Q XIA X A MAUREEN C | 2007 | J Geophys Res2007，112，2201： | 1 |
| 6 | Addressing the nurse shortage to improve the quality of patient care显示文摘 | Susan BH Maureen C | 2006 | Health Affairs2006，25，1： | 1 |
| 7 | Structure and regulation of acetyl-CoA carboxyiase genes of metazoa显示文摘 | MICHAEL C B NIGEL T P MAUREEN T T | 2005 | Biochimica Biophysica Acta2005，1733，： | 1 |
| 8 | 早期乳腺癌最佳辅助化疗方案与人类表皮生长因子受体2阳性乳腺癌辅助靶向治疗选择:依据 ASCO 对 CCO临床实践指南的改编显示文摘目的研究加拿大安大略癌症治疗中心(CCO)关于早期乳腺癌最佳辅助化疗方案,包括人类表皮生长因子受体2(HER2)阳性乳腺癌辅助靶向治疗方案,并对其进行改编。方法按照美国临床肿瘤协会(ASCO)对其他组织临床实践指南改编的策略和程序,对CCO临床实践指南的严谨性与内容适用性进行回顾。结果基于对CCO临床实践指南内容的回顾,ASCO小组认为,CCO临床实践指南在整体上清晰全面,以最确切的科学证据为基础,为患者提供可接受的治疗选项。推荐关于辅助化疗方案的决定,应考虑到基线复发风险、毒性、利益可能性和宿主因素(如合并症)。对于高风险HER2阴性的身体状况良好的人群,蒽环类和紫杉烷治疗方案是标准治疗方案。4个周期的多西他赛和环磷酰胺治疗方案是可接受的非蒽环类治疗方案。对于高风险HER2阳性患者,推荐蒽环类与紫杉烷序贯疗法联合曲妥单抗或多西他赛、卡铂、曲妥单抗进行6个周期的治疗。对于低风险、非淋巴结转移、HER2阳性人群,推荐每周一次的紫杉醇和曲妥单抗连续进行12个周期的替代治疗。曲妥单抗应持续使用1年。不应采用铂复合盐对三阴性人群进行常规的辅助管理,除非出现有效的生存数据加以支持。 | Neelima Denduluri Mark R Somerfield Andrea Eisen Jamie N Holloway Arti Hurria Tari A King Gary H Lyman Ann H Partridge Melinda L Telli Maureen E Trudeau Antonio C Wolff 本刊编辑部 | 2016 | 中国全科医学2016，19，18： | 1 |
| 9 | Child sexual abuse:from prevention to selfprotection显示文摘 | Maureen C Kenny Vjolca Capri Reena R ThakkarKolar | 2008 | Child Abuse Review2008，17，： | 1 |
| 10 | Younger women with breast carcinoma have a poorer prognosis the Han older women 显示文摘 | Maureen C Helena R Kirby B | 1996 | Caneer1996，77，3： | 1 |
| 11 | An Innovative Approach to the Care of Patients on Phase Ⅰ and Phase Ⅱ Clinical Trials:The Role of the Experimental Therapeutics Nurse显示文摘 | Claire C Maureen R Anne H | 2005 | Pediatric Oncology Nursing2005，22，6： | 1 |
| 12 | One-year outcomes of panretinal photocoagulation in proliferative diabetic retinopathy显示文摘 | Richard S Kaiser Maureen G Maguire Juan E Grunwald Douglas Lieb Binoy Jani Alexander J Brucker Albert M Maguire Allen C Ho Stuart L Fine | 2000 | American Journal of Ophthalmology2000，，2： | 1 |
| 13 | Impact of conditioning regimen on peripheral blood hematopoietic cell transplant显示文摘AIM To investigate infused hematopoietic cell doses and their interaction with conditioning regimen intensity +/-total body irradiation(TBI) on outcomes after peripheral blood hematopoietic cell transplant(PBHCT).METHODS Our retrospective cohort included 247 patients receiving a first, T-replete, human leukocyte antigen-matched allogeneic PBHCT and treated between 2001 and2012. Correlations were calculated using the Pearson product-moment correlation coefficient. Overall survival and progression free survival curves were generated using the Kaplan-Meier method and compared using the log-rank test.RESULTS Neutrophil engraftment was significantly faster after reduced intensity TBI based conditioning [reduced intensity conditioning(RIC) + TBI] and > 4 × 10~6 CD34+cells/kg infused. A higher total nucleated cell dose led to a higher incidence of grade II-IV acute graft-versus-host disease in the myeloablative + TBI regimen group(P = 0.03), but no significant difference in grade III-IV graft-versus-host disease. A higher total nucleated cell dose was also associated with increased incidence of moderate/severe chronic graft-versus-host disease, regardless ofconditioning regimen. Overall and progression-free survival were significantly better in patients with a RIC + TBI regimen and total nucleated cell dose > 8 ×10~8/kg(3 years, overall survival: 70% vs 38%, P = 0.02, 3 years, progression free survival: 64% vs 38%, P = 0.02).CONCLUSION TBI and conditioning intensity may alter the relationship between infused cell doses and outcomes after PBHCT. Immune cell subsets may predict improved survival after unmanipulated PBHCT. | Michael Burns Anurag K Singh Carrie C Hoefer Yali Zhang Paul K Wallace George L Chen Alexis Platek Timothy B Winslow Austin J Iovoli Christopher Choi Maureen Ross Philip L McCarthy Theresa Hahn | 2019 | World Journal of Clinical Oncology2019，10，2： | 1 |
| 14 | Growth of very low birth weight infant to age 20 year显示文摘 | Maureen H Mark S Lydia C | 2003 | J Pediatr2003，112，： | 1 |
| 15 | An outbreak of colonization with linezolid-resistant Staphylococcus epidermidis in an intensive therapy unit显示文摘 | Sinead K Jonathan C Maureen M | 2008 | Antimicrobial Chemother2008，61，： | 1 |
| 16 | Review of Determination Instream Flow Requirements with Special Application to Australia显示文摘 | Khalid K Maureen E G Ian C G | 1995 | Water resources Bulletin1995，31，6： | 1 |
| 17 | Metabolites from an antarctic sponge-associated bacterium Pseudomonasae ruginosa 显示文摘 | Jayatilake G S Maureen P T Alan C L | 1996 | J Nat Prod1996，59，3： | 1 |
| 18 | Primary adhesion of Enteromorpha(Chlorophyta,Ulvales)propagules:quantitative settlement studies and video microscopy显示文摘 | Maureen E C James A C Jeremy D | 1997 | Journal of phycology1997，，33： | 1 |
| 19 | The Influence of Surface Wettability on the Adhesion Strength of Settled Spores of the Green Alga Enteromorpha and the Diatom Amphora显示文摘 | Finlay J A Maureen E C Linnea K I | 2002 | Integrative Comparative Biology2002，，42： | 1 |
| 20 | The influence of sudace energy on the wetting behaviour of the spore adhesive of the marine alga Ulva linza(synonym Enteromorpha linza)显示文摘 | Callow J A Maureen E C Ista L K | 2005 | J R Interface2005，，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员